Changing the Practice of Medicine
Popular
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
- CME/CE Broadcast Replay
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
1.00 creditRobert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Jennifer Johnson, MD, PhD
- MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
CME/CE
- MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
David T. Rubin, MD
Ugo Iroku, MD, MHS
Florence Odufalu, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
Clinical Practice
- MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
2.00 credits 3 episodesDavid T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Jennifer Johnson, MD, PhD
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
- MinuteCE®
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
1.00 credit 7 episodesDavid T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
Michael Dolinger, MD, MBA
Programs
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Ravindra Uppaluri, MD, PhD
Nancy Lee, MD, FASTRO
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Christyn Edmundson, MD
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN